Ibrutinib | CAS 936563-96-1 - Request Quote
Ibrutinib
| SZ CAT No: | SZ-I005001 |
| CAS No | 936563-96-1 |
| Mol.F. | C25H24N6O2 |
| Mol.Wt. | 440.5 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ibrutinib is chemically 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one; PCI 32765; PCI 32765-00; CRA 032765; (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one. It is also known as Ibrutinib R-Isomer. Ibrutinib is supplied with detailed characterization data compliant with regulatory guideline. Ibrutinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ibrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 936563-96-1
Purchase 936563-96-1
Order 936563-96-1
Enquire 936563-96-1
price of 936563-96-1
936563-96-1 Supplier
936563-96-1 Manufacturer
936563-96-1 Exporter
buy high quality Ibrutinib
Purchase Ibrutinib
Ibrutinib suppliers
Ibrutinib manufacturers
Ibrutinib price
Order Ibrutinib
Enquire Ibrutinib
Ibrutinib cost
Ibrutinib Supplier
Ibrutinib Distributor
Ibrutinib for Method Validation
Ibrutinib Reference Standard
Ibrutinib for ANDA Filing
Ibrutinib for Forced Degradation Studies
Ibrutinib Identification Standards
Ibrutinib for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


